“The approval of Gardasil for use in males 9-26 years old in China is a significant step forward in advancing public health,” said Joseph Romanelli, president, Human Health International, Merck.

The recipient in Changsha, the capital of Hunan province, became the first man on the Chinese mainland to receive the HPV vaccine, after US pharmaceutical giant Merck announced its quadrivalent ...

"Since the approval of Merck's HPV vaccine in China, it has benefited the health of over 51 million Chinese women. We believe the new indications will continue to protect more eligible men," said ...

Welcome to Swords Traffic Management. A leading supplier of traffic management vehicles and equipment in the UK and Ireland. Sale and hire of traffic management vehicles and equipment Manufacture of ...

US pharmaceutical company Merck & Co ... papillomavirus vaccine has been approved for men aged 9 to 26 by China's top drug regulator. The vaccine that protects against four HPV strains is the ...

Here we summarize the historical developments leading to the prophylactic HPV vaccines and discuss current advances of next-generation vaccines that aim to overcome certain limitations of the VLP ...

RAHWAY, N.J. - Merck (NS:PROR) & Co., Inc. (NYSE ... the use of GARDASIL® for males aged 9 to 26. This marks the vaccine as the first in China to prevent certain human papillomavirus (HPV)-related ...

Merck & Co's human papillomavirus (HPV) vaccine, Gardasil, has received approval from China's medical products administration for men aged 9-26 years. Gardasil, a key product for Merck alongside its ...